strategic options

3D Binoculars with Question Mark Cubes - Colored Background - 3D Rendering
Favicon Fierce Biotech

Karyopharm lays off 20% of staffers amid hunt for alternatives

At the end of last year, Karyopharm recorded an accumulated deficit of $1.6 billion, according to an annual report.
Gabrielle Masson Jul 11, 2025 11:02am
failure crash no fail rocket cancelled end

Tracon seeks strategic options after injectable PD-L1 drug flop

Jul 2, 2024 4:32pm
contract

Pharma execs wary of value-based contracting: PwC

Sep 22, 2017 10:30am